Introduction
1.1 Muconic acid is an important platform molecule for production of bio-based polymers.
To date, cis,cis-muconic acid (ccMA) has been produced from multiple types of carbon sources including carbohydrates and aromatic compounds via cultivation with genetically engineered microbes [1] . Accurate analysis of muconic acid has previously been a challenge due to ccMA isomerization into cis,trans-muconic acid (ctMA). Isomerization of muconic acid from ccMA to ctMA appears to be initiated by a drop in pH (below 7) and/or with the addition of heat. Heat also leads to the creation of side products such as muconolactone (Mlac) and tetrahydrofuro [3,2-b] furan-2,5-dione (Lac2) (see Appendices Figure 1 ).
1.2 Generally, the complications that arise with the analysis of muconic acid are twofold:
(1) the inability of common chromatographic techniques to resolve ccMA and ctMA and (2) lack of suitable standards. Common methods for the analysis of biological acids, such as high-performance liquid chromatography (HPLC) methods using ionic hydrogen columns (i.e., Phenomenex Rezex RFQ-Fast Acid or BioRad Aminex HPX-87H), are not suitable to resolve both ccMA and ctMA. The current lack of a commercially available ctMA analytical standard makes it difficult to determine detector response. Accurate chromatographic quantitation (i.e., gas chromatography, liquid chromatography [LC], etc.) requires a detector response from varying concentrations of pure standards to construct individual compound calibration curves for each isomer. In addition to having differing detector responses, muconic acid isomers also differ in water solubility (ccMA = ~1 g/L and ctMA = 5.2 g/L) [2] , which further amplifies quantitative inaccuracy in analytical methods that fail to analyze both isomers separately. Each of these issues results in less accurate overall muconic acid quantitation in biological samples.
1.3
This procedure accurately and separately determines the concentrations of ccMA and ctMA representing total muconic acid in biological conversion samples. In this procedure, a purchasable authentic ccMA standard is used for detector response and biological sample quantitation of ccMA by HPLC with diode array detection (DAD) and refractive index detection (RID). Separately, this procedure provides a method to convert the purchasable ccMA to ctMA to produce the ctMA standard isomer used for detector response and quantitation by the same LC methods. The chromatography methods presented here have been tested to ensure that they do not induce further isomerization of ccMA.
1.4 This procedure also addresses matrix effects, whether media-or substrate-based, on muconic acid isomers regarding accurate quantitation of total muconic acid. A matrix media spike (MMS) is implemented as a confirmation of dependable analysis, or if necessary, when sample dilutions are required.
Scope
2.1 This procedure is used to separately quantify ccMA and ctMA as the total sum of muconic acid present in the liquid fraction of pretreated biological samples.
2.2 Analysis of trans, trans-muconic acid (ttMA) is outside the scope of this work, since ttMA production has not be observed in biological samples. The pathway to produce ttMA from ccMA differs from the lactonization pathway, and intermediate compounds from alternative pathways have not been studied with application to the methods presented in this procedure.
2.3
Sample matrices appropriate to methods presented in this procedure include M9 minimal media, herbaceous feedstock-based alkaline pretreated liquor [3] , base catalyzed depolymerized liquor [4] , and deacetylated mechanically refined liquor with enzymatic hydrolysis [5, 6] . These methods are not appropriate for whole slurry or acidic samples, only the liquid fractions of the aforementioned pretreatment types.
2.4
This procedure is appropriate for samples containing muconic acid, glucose, gluconate, 2-ketogluconate, and aromatic monomers and aromatic dimers present in the previously described pretreated lignin matrices. Any sample and/or matrix containing interfering components (such as co-eluting constituents) must be further investigated.
2.5 All analyses should be performed in accordance with an appropriate laboratory-specific quality assurance plan (QAP).
Terminology

Calibration Standard:
A set of standards, each at a known concentration, that are used to determine a detector response. The calibration standards must include the analytes of interest and be run in series with a sample set. The detector response can then be used to predict the concentration of an analyte in a sample.
Check Verification Standard (CVS):
An independent standard prepared from a different stock solution at a different concentration than the calibration standards. The concentration of the CVS should be set in the middle of the chosen calibration range and is used to ensure the calibration remains accurate throughout the entirety of the sample run. Additional CVS concentrations at the lower or higher end of the calibration curve can also be run to ensure accuracy of sample respective concentrations.
Media Matrix Spike (MMS):
The addition of the analyte(s) of interest at a known concentration into a media blank. This standard is used to evaluate the effects of the sample matrices on the performance of the analytical method. Extreme levels of pH, ionic strength, or the concentration of naturally occurring organic matter in the sample can enhance or decrease the detector response, resulting in unreliable analyte quantitation.
Significance and Use
4.1 This procedure is used to determine total muconic acid in the liquid fraction pretreated biological samples. This procedure may be used in conjunction with other methods to characterize and track other metabolites and sources of carbon such as the NREL laboratory analytical procedures "Determination of Sugars, Byproducts, and Degradation Products in Liquid Fraction Process Samples" and "Determination of Structural Carbohydrates and Lignin in Biomass."
Interferences
5.1 With samples that have been exposed to acidic conditions (pH below 7) for prolonged periods of time, any ctMA present will likely undergo further conversion into lactones along the lactonization pathway, resulting in an inaccurate total muconic acid quantitation. The addition of heat reduces the reaction time to lactonization. Lactones are not quantified in this method and cannot currently be quantified as there are no available standards. Lactone standards cannot be produced in the same manner as ctMA, due to the reaction equilibrium of Mlac and Lac2 (see Appendices Figure 1 ).
5.
2 Biological samples exposed to irradiation with ultraviolet light, iodine in acetonitrile, or specific catalysts such as palladium on carbon, produce ttMA in a separate reaction pathway from the lactonization pathway. Analysis of ttMA is outside the scope of this work.
5.3
In this method, muconic acid isomers appear to be sensitive to specific media matrices, often appearing as double peaks. Media matrix effects should be tested by using an MMS as previously defined. Dilution of samples may be necessary.
5.4
This method is not appropriate if analytes from sample and/or media co-elute with either muconic acid isomer. The muconic acid should be completely dissolved before using or the concentration of the standard will be unknown. Record the date of preparation, concentration, and any other pertinent information on the vial and store sealed at 4°C for up to 4 months (stability study ongoing).
Apparatus
10.1.4 Prepare the ctMA stock standard by preheating a water bath to 60 ± 3°C. Weigh exactly 40.0 mg of the ccMA standard into a 40-mL amber vial (vial REQUIRED as ordered per Step 7.2.1; vial variation will lead to heat transfer difference and the reaction time will either lead to incomplete ctMA formation or lactone formation). Record the weight of the standard to the nearest 0.1 mg. Add 39.934 mL HPLC-grade water or similar using a repeater pipette and mix well. Record the concentration of the standard, date of preparation, and any other pertinent information on the vial. Seal the standard with compatible vial top and place into the water bath so that the liquid in the vial is completely submerged for 2 hours. Shake every 15 minutes (use personal protective equipment as necessary). After 2 hours, immediately add 66 µL 10N sodium hydroxide using an air displacement pipette and mix. Store the sealed vial at 4°C for up to 4 months (stability study ongoing). Table 2 .
10.2.3
Use the calibration response factor obtained from the resulting linear calibration curve for ccMA and only work up data when the calibration quality of correlation is 0.995 or better. Response factors will differ between ccMA and ctMA; it is important to use the respective calibration curves to determine quantitation. 10.2.7 Use the calibration response factor obtained from the resulting linear calibration curve for ctMA and only work up data when the calibration quality of correlation is 0.995 or better. Response factors will differ between ccMA and ctMA; it is important to use the respective calibration curves to determine quantitation.
10.2.8
Prepare an independent CVS for each set of calibration standards. Use reagents from a source or lot other than that used in preparing the calibration standards.
Prepare the CVS at a concentration that falls in the middle of the validated range of the calibration curve. The CVS should be analyzed on the HPLC after each calibration set and should be included in the sequence table every 10 to 20 samples and at the end of the run to ensure the calibration holds throughout the analysis. The CVS is used to verify the quality and stability of the calibration curve(s) throughout the run. 10.3.2 Any dilution necessary must be carefully balanced because over dilution will decrease the concentration of muconic acid when applied to the samples, possibly below the limit of quantitation. The suggested dilution factor is five for a media matrix with a M9 composition. 
Where: X1 and X2 = measured values Xmean = the mean of X1 and X2 11.6 To report or calculate the root mean square (RMS) deviation or the standard deviation (stdev) of the samples, use the following calculations.
First find the RMS of the sample using:
Then find the root mean square deviation, or stdev, using:
Where: xm = the root mean square of all x values in the set n = number of samples in set xi = a measured value from the set 12. Report Format 12.1 Report each muconic acid isomer and the total muconic acid in each sample as a concentration in µg/mL. RPD and RMS deviation may also be reported.
Precision and Bias
13.1 Precision and bias need to be determined by data quality objectives and laboratoryspecific QAP. 14.3 Blank: 0.05% sodium hydroxide solution blank and media blank are used to ensure no co-eluting peaks and that there are no detectable compounds present in the media or sodium hydroxide solution due to contamination upon preparation.
Quality Control
14.4
Relative Percent Difference Criteria: Criteria need to be determined by data quality objectives and laboratory-specific QAP.
Calibration Verification
Standard: ccMA and ctMA should be independently produced from a different stock and a different concentration to that of the standards used in the calibration curve.
14.6
Sample Size: A sample volume of greater than 1 mL is required for filtering, possible dilutions, and proper injection from a standard 2-mL LC vial. If less than 1 mL sample volume is available, vial inserts may be used.
Sample Storage:
It is recommended that all samples be neutralized or brought up to a pH higher than 7, sealed, and stored in a freezer (-20°C or -80°C). Samples have been tested and determined stable with storage up to one month.
14.9 Standard Storage: Muconic acid standards should be stored upright in a fridge (4°C) until required. Stability studies are ongoing; however, samples have been tested and determined stable up to four months.
Definition of a Batch:
A batch is any number of samples that are analyzed and recorded together. The maximum size of a batch will be limited by the equipment constraints. 
Appendices
